Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.54 PB Ratio: 8.47 GF Score: 88/100

Half Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript

Jul 27, 2020 / 01:00PM GMT
Release Date Price: €30.6
Operator

Welcome to ROVI First Half 2020 Financial Results. The management of ROVI will bring you through the presentation, which will be followed by a Q&A session. Mr. Juan López-Belmonte, Chief Executive Officer; and Mr. Javier López-Belmonte, Chief Financial Officer of ROVI will be presenting this conference.

I pass the word to Mr. Javier López-Belmonte.

Javier López;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO

Thank you, Denise, and good afternoon to everyone. This is Javier López-Belmonte, Chief Financial Officer of ROVI. At this time, I would like to welcome everybody to this first half 2020 results conference call, which will start in a moment.

Let me please first introduce ROVI's attendees today: Juan López-Belmonte, CEO; Marta Campos, Investor Relations; Antonio Marquina, Investor Relations; and myself. (Operator Instructions) The conference will also be webcasted on ROVI website. After the presentation, as the operator said, there will be a question-and-answer session.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot